Background. The study presents data on a sample of children under one year of age hospitalized with lower respiratory tract infections (LRTIs) in Lithuania and Estonia.
INTRODUCTION
Lower respiratory tract infections (LRTIs) are a major cause of morbidity in infants and children worldwide. The respiratory syncytial virus (RSV), influenza, the human parainfluenza virus (1) , and the human metapneumovirus (2) are several of the viruses responsible for LRTI hospitalization in infants. RSV, an enveloped single-stranded RNA virus of the Paramyxoviridae virus family, is the most common cause of LRTI in children below one year of age (3) .
The respiratory syncytial virus is transmitted by aerosolized droplets or by direct contact with secretions or contaminated surfaces (3) . The incubation period for RSV is 2-8 days on average (3) . Initial symptoms of infection include congestion and coryza (rhinitis), often accompanied by a lowgrade fever; at this point, RSV is usually confined to the nasopharynx. However, 2-5 days after the onset of symptoms, the infection may spread to the lower respiratory tract (4) .
Virtually all individuals experience RSV infection within the first two years of life, usually within the first 12 months (3). This initial infection is symptomatic for bronchiolitis and pneumonia in 25% to 40% of infants and young children (5) . Fortunately, most infants and young children who are symptomatic for RSV infection recover fully in 8 to 15 days; however, 0.5% to 2% of all infants and young children require hospitalization during their first RSV infection (6) .
Infants with pre-existing diseases are at an increased risk of a serious debilitating disease during the RSV season. Bronchopulmonary dysplasia and a congenital heart disease are examples of conditions that increase the risk of serious RSV complications in infants. Other risk factors include pulmonary consolidation on chest radiography, premature birth, and hospitalization during the RSV season (the risk correlates directly with the length of hospital stay) (7) . Such environmental factors as exposure to passive cigarette smoke and crowded living conditions also increase the risk of serious RSV complications.
RSV infection is highly predictable on an annual basis. The time of year when RSV outbreaks usually occur is called the RSV season. In the Northern Hemisphere, the RSV season begins in October and ends in April (8) .
An epidemiologic survey was conducted in Central Eastern European (CEE) region to characterize the onset, peak, and duration of the RSV season, as well as the incidence and the outcome of hospitalization due to LRTIs caused by RSV in children below one year of age. The main results of this study have been published elsewhere (9) . Here we present the data on a selected sample of children below one year of age hospitalized with LRTI (age distribution, risk factors, need for a supportive treatment, and outcome of hospitalization) in two Baltic countries -Lithuania and Estonia.
METHODS
This was a retrospective, cross-sectional, observational, multi-country epidemiologic survey conducted in 12 countries of the CEE region (Bosnia/ Herzegovina, Bulgaria, Croatia, the Czech Republic, Estonia, Hungary, Lithuania, Romania, Serbia, Slovakia, Slovenia, and Ukraine). The protocol of the survey was reviewed and approved by national ethics committees. The population studied included children with LRTI, below one year of age, who were admitted to participating hospitals between October 2009 and April 2010 and/or October 2010 and April 2011 (two consecutive RSV seasons).
Eligible subjects were children below one year of age, hospitalized for LRTI (bronchiolitis, pneumonia), and for whom rapid diagnostic test (RDT) for RSV was performed. The following exclusion criteria were applied: children above one year of age and children without information on gestational age, gestational body weight, dates of hospitalization and hospital discharge, and the outcome of hospitalization. For each enrolled patient, informed consent was obtained from the parents, guardians, or legal representatives.
Selection of investigators was based on their prior research experience, expertise in the care of children with LRTI, ability to appropriately perform the survey, and their overall interest in participating in this study. Physicians at Children's Hospital Affiliate of Vilnius University Hospital Santaros Klinikos (<50 beds for infants below one year of age available) and Tallinn Children's Hospital, equipped with 35 beds, participated in this survey.
On the day of hospital discharge or during the first check-up visit after LRTI hospitalization, a physician completed a study questionnaire requesting the following information: demographics (gender, age, gestational age, gestational weight and height), risk factors, patient status at admission, RSV diagnostic procedure, treatment course, and the outcome of disease. The Lithuanian site reported the application of an immunochromatographic method (e.g., BD Directigen RSV, RSV Respi-Strip), whereas the Estonian site applied an immunofluorescense and polymerase chain reaction method to test for RSV infection.
Descriptive statistics were applied for data analysis. Statistical software SAS 9.1.2 (SAS Institute, Cary, NC, USA) was used for statistical data analysis.
RESULTS
In total, 3841 records were collected in the 12 participating countries during both seasons, with 3474 cases (90.4%) fulfilling the case definition (i.e., children less than one year of age hospitalized with a diagnosis of bronchiolitis and/or pneumonia within the observational periods). Of this number, 258 case report forms were completed at the Lithuanian site and 289 case report forms were completed at the Estonian site. Among them, four Lithuanian records (1.6%) and 61 Estonian records (21.1%) did not fulfil the case definition of this survey and were not included in the analysis. This resulted in 254 Lithuanian and 228 Estonian documented records fulfilling the definition for an LRTI case, which accounted for 13.9% of the entire survey population. A total of 297 LRTI cases were recorded in season 1 (October 2009-April 2010) and 185 cases were recorded in season 2 (October 2010-April 2011). Table 1 presents the time course of case collection during both seasons in each country separately.
Patient characteristics are summarized in Table 2. Male patients accounted for slightly more than half of all documented LRTI cases (58.3% in Lithuania and 56.1% in Estonia). The majority of hospitalized LRTI patients were less than six months of age. The proportion of premature infants (gestational age of ≤36 weeks) accounted for just over 10% of documented LRTI cases in Lithuania and Estonia; this proportion was almost two times lower than that in the entire survey population (21.8%). The prevalence of concomitant chronic diseases at admission in both Baltic countries was also considerably lower (Table 2) than the rates in the full survey population. At admission, bronchiolitis was the most common diagnosis of LRTI cases in both countries; pneumonia was diagnosed in about 15% of LRTI cases (Table 3 ). Considerable differences between the two countries were observed in the state of consciousness on admission. In Lithuania, 36.6% of hospitalized cases were alert and conscious at admission, whereas in Estonia, 83.3% of cases were conscious at admission.
RSV rapid tests were performed for all documented LRTI cases in Estonia and for 99.6% cases in Lithuania. The aetiology of RSV was confirmed in 87.3% of the tested LRTI cases in Estonia. In Lithuania, the proportion of confirmed RSV cases was lower (54.2%) and was closer to the rates observed in the full survey population (42.4%).
The mean duration of hospital stay was ten days in Lithuania and seven days in Estonia. In this study, more than 40% of patients with LRTIs in Lithuania and over 30% of cases in Estonia stayed in hospital longer than one week. Intensive care unit (ICU) hospitalization was required for 9.1% of LRTI cases in Lithuania and in 3.1% of cases in Estonia. In LRTI cases transferred to the ICU, the mean duration of stay in the ICU was six days in Lithuania and four days in Estonia (Table 4) .
Supplemental oxygen was required for 23.2% of LRTI cases in Lithuania and 31.6% of LRTI cases in Estonia. In LRTI cases with supplemental oxygen administration, the mean duration of oxygen administration was seven days in Lithuania and three days in Estonia. The majority of patients with LRTIs received treatment with bronchodilatators (Table 4). In Lithuania, complete recovery at discharge was assessed for 35.8% of LRTI cases and improvement was observed in 62.2% of cases. In Estonia, all LRTI cases were improved at discharge, and there were no complete recoveries.
DISCUSSION
Approximately 22% of all episodes of acute LRTIs in children below five years of age are associated with RSV. A substantial proportion of RSV-associated morbidity occurs in the first year of life, with an incidence in infants that is twice or three times greater than is reported for children below five years overall (10) . We present the data describing a selected sample of children younger than one year of age hospitalized with LRTI during two consecutive RSV seasons in two health care centres in Lithuania and Estonia. Out of 482 Well-established disease-and patient-specific risk factors, including congenital heart disease, bronchopulmonary dysplasia, and premature birth, have consistently been found to increase the likelihood of a serious RSV disease. The risk of a serious RSV illness in premature infants is increased if they attend a childcare facility or share a dwelling with multiple siblings or other children. Conditions that compromise handling of respiratory tract secretions, such as congenital abnormalities of the airway and severe neuromuscular disease, are also largely believed to increase the risk of a serious RSV disease (11) (12) (13) . The parent study reported a more severe course of RSV-related LRTI infection among premature children compared to full-term children (9) . In our sample, the established risk factors (i.e., prematurity, concomitant chronic diseases) were relatively less prevalent than in the full survey population.
We observed some differences in the management of enrolled patients between the sites, namely, the duration of hospitalisation and ICU hospitalisation, as well as duration of supplemental oxygen administration. Such findings might be influenced by the severity of the condition of the enrolled patients (e.g., there were considerably fewer alert patients on admission at the Lithuanian site compared to the Estonian site). Also, there were differences in patients' status at discharge -about one-third of discharged patients were completely recovered in Lithuania, whereas all the discharged patients in Estonia were improved but none completely recovered. The latter difference might be related to different local clinical practices in the management of such patients and to the definition of complete recovery.
The results of this study need to be interpreted with caution. Firstly, the data were recorded in a retrospective manner which might have resulted in some recall bias. Secondly, only two health care centres (one in each country) participated in the study, therefore the reported findings might not represent the whole country.
CONCLUSIONS
RSV was highly prevalent among children younger than one year of age hospitalized for LRTIs in Lithuania (54.2%) and Estonia (87.3%). Bronchiolitis was the most common diagnosis in hospitalized patients.
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